Velsipity 2 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F5W0E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,521
Award facts
- Contract value 100% obligated
- $17,521.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $17,521.25 to AmerisourceBergen Drug Corp for the supply of Velsipity 2 mg tablets (30-count units). The contract, issued on January 22, 2026, with an ultimate completion date of January 23, 2026, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with its parent company being Cencora, Inc. (doing business as AmerisourceBergen). This delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion contract running through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare programs worldwide.
AmerisourceBergen's role as a pharmaceutical prime vendor for the Defense Logistics Agency reflects its critical position in the federal medical supply chain, particularly for military treatment facilities and veteran healthcare systems. The delivery of Velsipity, a prescription medication used in diabetes management, exemplifies the company's responsibility for supplying a diverse portfolio of brand-name and generic pharmaceuticals across multiple therapeutic domains. The expedited completion timeline suggests this represents a routine replenishment order under the established IDC vehicle, enabling the DLA to efficiently procure essential medications required by military medical operations globally.
Quick answers
Who was awarded contract SPE2DR26F5W0E?
SPE2DR26F5W0E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F5W0E worth?
The government has obligated $17,521 on SPE2DR26F5W0E.
Is contract SPE2DR26F5W0E an order under another contract?
Yes. SPE2DR26F5W0E is a delivery order under SPE2DR25D3404, an indefinite delivery contract.
Was contract SPE2DR26F5W0E competed?
The extent of competition for SPE2DR26F5W0E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award